DNLI Financials

Denali Therapeutics Inc - Financial statements & key metrics

Stock Price

$23.30

Market Cap

$2.11B

P/E Ratio

-9.1

EPS

$-2.92

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-422.77M

EPS (Diluted)

$-2.57

Balance Sheet Highlights

Total Assets

$1.37B

Total Liabilities

$144.50M

Shareholders Equity

Cash & Equivalents

$174.96M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-347.69M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-44.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is DNLI revenue?

View DNLI's income statement for detailed revenue data.

Is DNLI profitable?

DNLI reported a loss of $422.77M in the most recent quarter.

What is DNLI market cap?

DNLI has a market capitalization of $2.11B, making it a mid-cap stock.

Does DNLI have debt?

View DNLI's balance sheet for debt information.

What is DNLI cash flow?

Cash flow data is available in the full financial statements.